Volrite 500 mg/ 1000 mg TABLETS
PDF Leaflet Revision Date: 24 March 2022
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of herpes zoster and recurrent genital herpes.
Dosage (summary)
1000 mg TID for herpes zoster; 500 mg BID for recurrent genital herpes.
Special Populations
- Elderly
- Renal impairment
Pregnancy & Breastfeeding
Safety not established; potential teratogenicity in animal studies.
Key Drug Interactions
- Cimetidine
- Probenecid
Contraindications
- Hypersensitivity to valaciclovir or aciclovir
Common side effects
- Headache
- Nausea
- Dizziness
Counselling Points
- Maintain hydration
- Monitor renal function
- Discontinue if CNS symptoms occur
Serious warnings
- Risk of TTP/HUS
- CNS adverse reactions
Important Disclaimer
The Volrite 500 mg/ 1000 mg TABLETS professional information leaflet below is the property of Aurogen South Africa and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
